Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 08, 2017 08:00 ET | Source: Cascadian Therapeutics, Inc.

Cascadian Therapeutics’ Lead Candidate, Tucatinib, Receives Orphan Drug Designation from FDA for Treatment of Breast Cancer Patients with Brain Metastases

SEATTLE, June 08, 2017 (GLOBE NEWSWIRE) -- Cascadian Therapeutics, Inc. (NASDAQ:CASC), a clinical-stage biopharmaceutical company, today announced that tucatinib, an investigational oral, small...
June 08, 2017 08:00 ET | Source: Fibrocell Science, Inc.

Fibrocell Completes Dosing of First Cohort in Phase 1/2 Clinical Trial of FCX-007 Gene Therapy for Treatment of Recessive Dystrophic Epidermolysis Bullosa

EXTON, Pa., June 08, 2017 (GLOBE NEWSWIRE) -- Fibrocell Science, Inc. (NASDAQ:FCSC), a gene therapy company focused on transformational autologous cell-based therapies for skin and connective tissue...
June 08, 2017 07:05 ET | Source: Myriad Genetics, Inc.

Crescendo Bioscience Announces Six Studies with Vectra® DA Will Be Presented at the 2017 Annual European Congress of Rheumatology

SALT LAKE CITY, June 08, 2017 (GLOBE NEWSWIRE) -- Crescendo Bioscience, a wholly-owned subsidiary of Myriad Genetics, Inc. (NASDAQ:MYGN), today announced that new data on the use of the Vectra® DA...
June 08, 2017 07:00 ET | Source: NewLink Genetics Corporation

NewLink Genetics to Regain Rights to GDC-0919

AMES, Iowa, June 08, 2017 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (NASDAQ:NLNK) today announced that on June 6, 2017, Genentech, a member of the Roche Group, informed NewLink Genetics that...
June 07, 2017 16:05 ET | Source: Organovo, Inc.

Organovo Announces Fiscal Fourth-Quarter and Full-Year 2017 Results; Company Issues Full-Year Fiscal 2018 Outlook

SAN DIEGO, June 07, 2017 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”) today reported financial results for the fiscal fourth quarter of 2017 and issued its full-year fiscal...
June 07, 2017 12:00 ET | Source: Alder BioPharmaceuticals, Inc.

Alder to Present Migraine Prevention Data for Eptinezumab at 59th Annual Scientific Meeting of the American Headache Society

BOTHELL, Wash., June 07, 2017 (GLOBE NEWSWIRE) -- Alder BioPharmaceuticals, Inc. (NASDAQ:ALDR), today announced four data presentations at the 59th Annual Scientific Meeting of the American Headache...
June 07, 2017 09:00 ET | Source: Yield10 Bioscience, Inc.

Yield10 Bioscience Starts Field Tests of Novel Yield Trait Gene C3003 in Oilseed Crops Camelina and Canola

WOBURN, Mass., June 07, 2017 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (NASDAQ:YTEN) today announced that planting has been completed at study sites in Canada for field tests to evaluate the...
June 07, 2017 08:00 ET | Source: Cell Design Labs

Cell Design Labs Announces Issuance of Broad Patent for Chimeric Notch (synNotch™) Receptor to Treat Cancer and Other Diseases

EMERYVILLE, Calif., June 07, 2017 (GLOBE NEWSWIRE) -- Cell Design Labs, Inc. today announced the issuance of U.S. Patent No. 9,670,281, entitled “Binding-triggered transcriptional switches and the...
June 06, 2017 09:00 ET | Source: AbCellera

AbCellera Announces an Antibody Discovery Program in Influenza Vaccine Research

VANCOUVER, British Columbia, June 06, 2017 (GLOBE NEWSWIRE) -- AbCellera has entered into a collaborative research effort with Sanofi Pasteur, a global leader in the development and sale of vaccines...
June 06, 2017 08:30 ET | Source: Galectin Therapeutics

Autoimmune Disease Patent Granted to Galectin Therapeutics

NORCROSS, Ga., June 06, 2017 (GLOBE NEWSWIRE) -- Galectin Therapeutics, Inc. (NASDAQ:GALT), the leading developer of therapeutics that target galectin proteins, today announced that the Company has...